Atomoxetine
Also known as: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine
Brand names: STRATTERA
Therapeutic Indications
Atomoxetine is indicated for:
Hyperkinetic disorders
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral
Treatment 2: Oral
Hyperkinetic disorders
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral
Contraindications
Active ingredient Atomoxetine is contraindicated in the following cases:
No gender/age discrimination
at least one of
MAO inhibitors
Primary angle-closure glaucoma
Pheochromocytoma
Primary angle-closure glaucoma
Pheochromocytoma
No gender/age discrimination
at least one of
Pregnancy
Lactation
Lactation